R&D Changing Faces: Pharma and biotech November-December 2024 Welcome to the last edition of Changing Faces for 2024.
Sales & Marketing Revitalising life sciences hiring: The case for creative rec... The labour market in the life sciences sector has stabilised, but employers are still finding it challenging to attract the best talent.
Market Access Balancing innovation and safety: The impact of Medtech regul... The Medtech sector is currently at a crossroads, facing a potential choice between rapid technological advancement and strict regulatory oversight.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires from... Another light month in March on the agency and investor side, but there are a few appointments worth noting.
Digital Changing Faces: Digital and supplier hires from March 2024 We’re back with another hires round-up for digital health companies and pharma suppliers. There was plenty of action across the sector in March.
R&D Changing Faces: Pharma and biotech hires from March 2024 Once again in March, the pharmaceutical world saw a series of notable hires. From biotech to pharma, companies are strengthening their teams with experienced professionals.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
